Tokyo, Dec. 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060116) titled 'Anti-wrinkle effects of medicated whitening serum containing four active ingredients' on Dec. 18.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Open -but assessor(s) are blinded
Control - No treatment
Primary Sponsor:
Institute - Japan Clinical Trial Association
Condition:
Condition - Healthy adult female
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Influence to the wrinkles when an adult female used medicated cosmetic serum for 4 weeks, is estimated
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Only one side of the face,using test article for 4 consecutive weeks
Interventions/Control_2 - The other side of the face, no using test article for 4 consecutive weeks
Eligibility:
Age-lower limit - 35
years-old
=
Gender - Female
Key inclusion criteria - Subjects whose wrinkle class in the outer corner of left and right is 1 to 3
Key exclusion criteria - 1. Subjects with cosmetic allergies
2. Subjects who are pregnant or lactating
3. Subjects with inflamed or scraped skin on face
4. Subjects who are judged as unsuitable for the study by the investigator for the other reason
Target Size - 12
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 10 Month 24 Day
Date of IRB - 2025 Year 11 Month 13 Day
Anticipated trial start date - 2025 Year 12 Month 18 Day
Last follow-up date - 2026 Year 01 Month 15 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068754
Disclaimer: Curated by HT Syndication.
